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Letters
To the Editor:
Re: Bouter L, Pennick V, Bombardier C. Cochrane Back
Review Group. Spine. 2003;28:1215-1218.
I read with great interest the recent report of Bouter et
al of the Cochrane Back Review Group (CBRG) regard-
ing its mission, scope, and activities. I was particularly
pleased to read of their recent recognition of the need to
“broaden the scope” of their work.
As reported in the article, historically, the only focus
of the CBRG has been on randomized controlled trials
(RCTs) of low back treatment interventions. Unfortu-
nately, these RCTs have provided minimal guidance in
managing low back pain (LBP), a result that more and
more are realizing will be perpetuated as long as such
studies continue to focus on nonspecific LBP rather than
on validated LBP subgroups.
Nonspecific, unhelpful outcomes are very much a
function of studying nonspecific groups. A commonly
cited analogy may help understanding: to determine the
efficacy of sublingual nitroglycerin, it is best to study a
subgroup with chest pain rather than studying everyone
with chest pain, regardless of its source. The high efficacy
of nitroglycerin for cardiac patients would be missed
completely by studying only nonspecific chest pain.
This point was addressed exceptionally well by
Spratt,1 who correctly stated that any RCT intended to
evaluate treatment efficacy must first establish the valid-
ity of an “assessment–diagnosis–treatment–outcome”
model consisting of three important links: assessment
linked to diagnosis, diagnosis linked to treatment, and
finally, treatment linked to outcome. Spratt stated that
none of these three links can be validated until all previ-
ous links have been established.1
RCTs of nonspecific LBP, Pratt stated, “generally fo-
cus only on the treatment–outcome link, without care-
fully and explicitly establishing the assessment–
diagnosis and diagnosis–treatment links.”1 For this
reason, Pratt indicated that RCTs of nonspecific LBP
“are doomed because they fail to establish all three links
and thus leave too many alternative explanations, or ri-
val hypotheses, for interpreting the results.”1 Without
adopting this research model, “the results of randomized
controlled trials will continue to be frustrating, meaning-
less, and even misleading,” resulting in “articles written
in another 25 years that suggest that Nachemson’s 1976
lament,2 that 85% of patients with LBP have no specific
diagnosis, remains as true as it was 50 years before.”
How tragic that would be!
Reports cited by Bouter et al of the Second Forum for
Primary Care Research in Low Back Pain agree by con-
cluding that the number 1 LBP research priority is the
identification of LBP subgroups and the criteria used to
differentiate them.3 Identifying these subgroups is the
essence of Spratt’s1 first two links and the foundation for
designing meaningful RCTs.
Bouter et al reported that the CBRG has more recently
recognized the importance of performing systematic re-
views of “etiological, diagnostic, and prognostic stud-
ies.” The importance of such studies and reviews is char-
acterized as providing the means to “answer the ‘Holy-
Grail’-type questions,” such as which interventions are
most effective for which patients and what are the most
important (preventable) predictors of chronicity. Obvi-
ously, these authors acknowledge the high priority of
non-RCTs focused at investigating diagnostic and prog-
nostic factors.
As such, it is then confusing why the CBRG continues
their exclusive review of RCTs that focus primarily on
Spratt’s treatment–outcome link and only on nonspecific
LBP. Why are its limited resources still only directed
toward systematic reviews of RCTs that, if we are to
believe Spratt, are “doomed,” even “misleading”1 and
will more likely detract from our progress than contrib-
ute to it? RCTs are simply the wrong study design for
investigating what we are now told should be our top
clinical research priority.
If the mission of the CBRG is to have a positive impact
on our understanding of the clinical management of LBP,
it must reconsider its funding priorities and work focus,
putting RCTs of nonspecific LBP at a somewhat lower
priority until RCTs of validated subgroups are available.
Meanwhile, the pursuit of studies that address their
“Holy-Grail” topics, i.e., subgroup identification and
outcome prediction, would seem a much more produc-
tive and beneficial direction for them to go at this time.
The Bouter et al article closes with an open invitation
for volunteers to help with their work. I, for one, would
be delighted to be part of their transition to include this
new focus on reviewing studies investigating the reliabil-
ity and validity of LBP subgroups.
Ronald Donelson, MD, MS
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In Response:
We appreciate Dr. Donelson’s interest in our article, and
we agree with some of his comments. We also believe
that evidence-based management of low back pain (LBP)
would improve if it were possible to identify subgroups
of patients for whom specific treatments were indicated.
We agree that randomized clinical trials (RCTs) can nei-
ther identify homogeneous subgroups of patients nor
lead to promising new treatments. However, this is not
what RCTs are meant to do, and the same holds for
systematic reviews of RCTs. The humble aim of both
study designs is to assess the effectiveness of a plausible
and/or widely used intervention in comparison to an al-
ternative, among patients with a putative indication for
both interventions.
When the results of an RCT or corresponding system-
atic review are negative, it may be because both interven-
tions are equally (in)effective, or it may be because the
study population is too heterogeneous. Of course,
chance findings or a suboptimal operationalization of
one or both interventions may also be an explanation of
the findings. We believe that this type of information is
important to inform clinical practice where many inter-
ventions are offered to patients with nonspecific LBP.
The mission of the Cochrane Collaboration is to summa-
rize the available evidence from RCTs on the effects of
health care interventions, but it does not in any way
claim that etiologic, diagnostic, prognostic, or clinimet-
ric systematic reviews are unimportant. Currently,
broadening the scope to include diagnostic reviews is
being considered, and the Back Review Group is eager to
participate in this development.
Since the publication of the Nachemson paper, cited
by Donelson, there has been no shortage of articles
claiming to identify clinically meaningful subgroups
within the domain of nonspecific LBP. Unfortunately,
however, very little progress has yet been made in the
search for this “Holy Grail.” Some nonbelievers even
dare to suggest that the “Holy Grail” doesn’t exist and
that we should instead focus on the common features of
a range of musculoskeletal disorders, for instance, non-
specific back, neck, and upper limb pain. The future will
teach us who is right. The Back Review Group is not in
the business of producing or funding the necessary new
primary studies. We will continue to focus on systematic
reviews of RCTs and try to broaden our scope gradually
to include other types of reviews. We strongly disagree
that our work is “doomed” or “misleading,” although
we do admit that we are unable to answer all the relevant
questions concerning LBP. However, the core business of
the Cochrane Back Review Group of carefully conduct-
ing systematic reviews of RCTs has played and still plays
an important role in identifying effective treatments for
low back and neck pain. This work has been used by
many guideline committees around the world and has
proven to be useful.
L. M. Bouter, PhD
V. Pennick, RN, BScN, MHSc
C. Bombardier, MD, FRCP
Institute for Research in Extramural Medicine
VU University Medical Center
Amsterdam, The Netherlands
To the Editor:
Re: Giles LG, Muller R. Chronic spinal pain: a random-
ized clinical trial comparing medication, acupuncture,
and spinal manipulation. Spine 2003;28:1490–502.
I read with pleasure this well-designed clinical article.
This study has tremendous clinical application for both
physicians and patients.
Tremendous amounts of sick leave and billions of dol-
lars are spent annually for spinal pain with the over-
whelming majority involving low back pain. As we all
know, more and more patients are seeking complemen-
tary and alternative medicine approaches for various ail-
ments, especially musculoskeletal conditions involving
the neck and low back.
Treating physicians are also beginning to realize the
overwhelming need and potential of alternative methods
for these often chronic and debilitating conditions in our
young, otherwise healthy, working population. This has
led to a recent upsurge in interest in treatment alterna-
tives for various musculoskeletal conditions with manip-
ulation on the forefront of these alternative methods. We
have seen recent articles on clinical outcomes following
manipulative treatment as well as recent symposia on
this subject at national integrative spine meetings such as
the North American Spine Society this past October. As
a spinal surgeon and chiropractor, in my nonsurgical
patient population, I often incorporate spinal manipula-
tion along with other treatment methods via a multidis-
ciplinary approach into my treatment algorithm with
positive results. This multidisciplinary approach to pa-
tient care is being utilized with increasing frequency
across the country, and it gives me great pleasure to wit-
ness the growing partnership between the allopathic and
homeopathic professions. It must be emphasized that
this study incorporated the most common form of ma-
nipulation involving a high velocity, low amplitude
thrust as their form of treatment, as there are other types
of “spinal manipulation” techniques. Furthermore, al-
though chiropractors perform the vast majority of spinal
manipulation, they are not the only health professionals
utilizing it. Future studies need to be performed with a
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larger patient base and longer follow-up. Finally, and
probably most importantly, I strongly feel that articles
like this will help to decrease the anxiety of both health
care professionals and their patients to seek manipulative
treatment either alone or as an adjunct and hopefully
allow a more complete array of cotreatment methods
that can offer patients pain relief and a better quality of
life. After all, our goal as doctors is to help alleviate pain
and suffering of patients without undue harm, so inter-
estingly enough, we have been on the same page all
along.
Jeff S. Silber, MD, DC
Department of Orthopedic Surgery
Long Island Jewish Medical Center
Great Neck, New York
In Response:
We thank Dr. Silber for his comments on our random-
ized clinical trial (RCT). We attempted to establish a
well-designed RCT as a basis for studies on spinal pain
syndromes that are costly to patients and cause tremen-
dous suffering and hardship. We agree that incorporat-
ing spinal manipulation with other treatment methods
via a multidisciplinary approach can have positive re-
sults. This reinforces the concept for establishing the
Multidisciplinary Spinal Pain Unit (MSPU) at Townsville
General Hospital (TGH) in July 1995. The Unit’s Mis-
sion Statement, in part, was “to provide a multidisci-
plinary focus for the diagnosis and treatment of spinal
pain sufferers. In addition, the Unit would collect data
for research and education with respect to the clinical
symptom of spinal pain. . .to lessen the human, social
and economic costs of this common, poorly understood,
and disabling condition.” The Unit’s primary intention
was to determine what patient satisfaction was to such
an approach and to ascertain which of three specific
treatment methods may be more beneficial for chronic
spinal pain sufferers, the objective being to enable pa-
tients to return to work and to live a normal life.
Cooperation between a hospital and a university, in
order to combine service provision for patients and a
legitimate research base, was achieved by the vision of
the then Director of Medical Services at TGH and the
then Vice-Chancellor of James Cook University, both of
whom facilitated the establishment of Australia’s first
hospital-based multidisciplinary spinal pain service pro-
vision and research activity. Initial funding for staff sal-
aries was provided by the university with the Australian
Medicare system allowing Medicare rebates for medical
practitioners for service provision. Subsequent funding
was via a philanthropist, then by a 4-year funding grant
from the State Government of Queensland to “enable the
work of the Unit to continue.”
In addition to the Unit’s multidisciplinary staff (med-
ical practitioner, chiropractor, acupuncturist, chiroprac-
tor/clinical anatomist) working as a team at TGH, the
goodwill of an orthopedic surgeon enabled the Unit to
request magnetic resonance imaging (MRI) studies,
when required, to ensure a thorough investigation of
patients. Imaging costs, therefore, were covered under
the Commonwealth of Australia Medicare system. In ad-
dition, a consultant psychiatrist, with an interest in
chronic pain, and who was the catalyst in the establish-
ment of the Unit, made it possible for any of the Unit’s
patients that were “at the end of their tether” due to
chronic spinal pain to be fitted into his busy private prac-
tice on short notice, as did a specialist in rehabilitation
medicine. These specialists had private practices outside
the public hospital system but only charged the Unit’s
essentially impecunious patients the Medicare rebate fee,
in effect subsidizing the Unit’s activities.
A patient satisfaction questionnaire showed that
85.9% of patients randomly surveyed gave a very posi-
tive response.1 This was gratifying, as most patients pre-
sented with serious and intractable spinal pain problems,
usually of considerable duration. We agree with Dr. Sil-
ber that a study with a larger patient base and longer
follow-up needs to be performed. When the Director of
the Unit requested ongoing service provision funding of
U.S. $192,000 per year for 3 years from Queensland
Health, funding was denied, which is regrettable, as it
took several years of negotiation to establish the unique
MSPU in an Australian hospital setting, and it provided a
valuable service to many general and specialist medical
practitioners and patients. Furthermore, over the Unit’s
7-year period of operation, it achieved its aims and goals
as stated in the Mission Statement. By denying funding,
the State Government effectively dismantled the flourish-
ing Unit, which is most unfortunate, as the period from
2000 to 2010 is the International Bone and Joint Decade.
Unless governments provide long-term funds to enable
multidisciplinary spinal pain units to address the huge
and skyrocketing problems associated with spinal pain,
they will continue to waste large amounts of taxpayer
funds on a noncohesive spinal pain health care system.
As Dr. Silber states, it is importance for patients to re-
ceive a complete array of cotreatment methods that can
offer them pain relief and a better quality of life.
We hope that the international response to the Unit’s
activities will lead to greater collaboration between cli-
nicians from different professional groups.
Lynton G. F. Giles, DC, MSc, PhD
Reinhold Muller, PhD
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To the Editor:
Re. Kleinstueck FS, Diederich CJ, Nau WH et al Tem-
perature and Thermal Dose Distributions During Intra-
discal Electrothermal Therapy in the Cadaveric Lumbar
Spine. Spine 2003;28:1700–8 and the accompanying
Point of View by Carragee EJ. Spine 2003;28:1709
Both the article by Kleinstueck et al and the point of
view following it are well written and informative, and
we recognize the time and effort required in such research
and discussion. We would like to further the discussion
regarding the position of the catheter during intradiscal
electrothermal therapy (IDET), and we appreciate the
opportunity this forum allows for such debate.
After assessing the temperatures and thermal dose dis-
tribution during IDET, the authors reported that temper-
atures were not reliably produced in clinically relevant
regions, such as the posterior anulus. Our understanding
from the method of this study was that the IDET catheter
was placed in the nucleus or inner anulus, and in reading
both discussions, a reader might assume that this is the
most common final catheter position used in clinical
practice. In the clinical setting, however, a more common
practice is to place the catheter in the outer anular fibers.
Karasek and Bogduk1 emphasized that the catheter po-
sition at all times is buried between the lamellas of the
anulus fibrosus 5 mm deep to its outer surface.
The IDET probe was developed as an improved
method of delivering thermal energy to target tissue.
Sluijter2 utilized a standard radiofrequency needle in-
serted into the center of the disc.3 Saal and Saal4 im-
proved the method using a catheter that could be navi-
gated within the disc. The original idea was to be able to
place catheter in outermost anular fibers where the ma-
jority of the pain fibers occur. Bilateral catheter inser-
tions were performed when needed to completely cover
the outer anulus and to improve outcomes some have
recommended placing the IDET catheter within 5 mm of
outer anulus.1 We also prefer to have the catheter placed
in close proximity to the majority of nerve fibers, and in
fact, when there has been significant posterior anular
disruption, it is difficult to navigate the catheter any-
where but the outermost anular fibers. With the catheter
within 5 to 6 mm of the outer anulus, the Kleinstueck et
al study showed that one can achieve sufficient thermal
doses capable of generating complete thermal damage to
the nociceptive nerve fibers. The provocation of concor-
dant pain recorded during IDET in the O’Neil et al
study5 was also based on the IDET procedure in which
catheters were often placed within the outer anular fi-
bers. Our recent study case reviews6 showed that 90% of
the time, the catheter was within 5 mm of the outer
anular fibers. In addition, we noted that outcomes were
poorer and postprocedural flare-ups were longer with
the recommended 90° protocol. When the catheter was
located in the outermost anular fibers, outcomes actually
improved with lower temperatures (85°) and shorter
than recommended total heating times (15 minutes).
In conclusion, we agree with both Kleinstueck et al
and Carragee’s concern for recommending a more ag-
gressive heating protocol based on the study findings,
and we feel that higher temperatures, longer heating
times, or both should be reserved for cases where the
catheter is within the nucleus or inner anulus. When the
catheter is in the outermost anular fibers, nociceptive
nerve fiber destruction with less collateral tissue damage
can probably be achieved at more conservative heating
protocols.
Richard Derby, MD
Sang-Heon Lee, MD, PhD
Spinal Diagnostic & Treatment Center
Daly City, California
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To the Editor:
Re: Foley KT, Holly LT, Schwender JD. Minimally in-
vasive lumbar fusion. Spine 2003;28:S26–35.
Having had the opportunity of reviewing numerous
articles for Spine before publication, it is not comforting
to see how this manuscript was published. There are two
major flaws in the manuscript that I would like to
outline.
1. Page S27 under the title Evolution of Minimally
Invasive Lumbar Fusion, a brief reference to the Leu and
Hauser work on percutaneous endoscopic interbody fu-
sion is made. However, the reported outcome of this
approach is not current.
The authors have failed to include Kambin’s scientific
presentations in the early 1990s and subsequent publica-
tions from 1995 and thereafter on percutaneous mini-
mally invasive lumbar fusion and percutaneous insertion
of pedicle screws through previously positioned cannulas
on the pedicle.1–5
2. Page S28, paragraph 4, the authors claim that the
tubular retractor system was first developed for micro-
discectomy by Foley and Smith in 1994, citing a refer-
ence that was published in 1997. It should be noted that
Kambin published his work on translaminar approach to
the content of the spinal canal via a 10 mm ID cannula as
early as 1995.3,4 In addition, the use of a larger diameter
598 Spine • Volume 29 • Number 5 • 2004
cannula for foraminal surgery was submitted to the U.S.
Patent Office in March 1994.6
Parviz Kambin, MD
Department of Orthopaedic Surgery
Drexel University College of Medicine
Philadelphia, Pennsylvania
References
1. Kambin P. Percutaneous fixation of vertebrae. U.S. Patent filed August 15,
1991. Patent #5,242,443 issued September, 1993.
2. Kambin P. The role of minimally invasive surgery in spinal disorders. Adv
Oper Orthop 1995;3:147–71.
3. Kambin P. Arthroscopic techniques for spinal surgery. In: McGinty JB, Cas-
peri RB, Jackson RW, et al, eds. Operative Arthroscopy. Philadelphia, PA:
Lippincott-Raven; 1996:1215–25.
4. Kambin P. Arthroscopic lumbar intervertebral fusion. In: Frymoyer JW,
Ducker T, Hadler N, et al, eds. The Adult Spine: Principles and Practice. New
York, NY: Raven Press; 1996:2037–47.
5. Kambin P, Gennarelli T, Hermantin F. Minimally invasive techniques in spi-
nal surgery: current practice. Neurosurg Focus 1998;4:1–10.
6. Kambin P. Arthroscopic foraminal surgical procedures. Patent application
filed March 8, 1994. Serial No. 08/207,831.
599Letters to the Editor
